ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Effects of IL-18 on Key Post-Translational Modifications of Human Foxp3 and Innate Immunity

    T. Akimova1, L. M. Christensen1, Z. Wang2, M. H. Levine2, W. W. Hancock1

    1CHOP & University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA

    *Purpose: Most of our ideas about Treg cells are extrapolated from findings in mice, with actual clinical data typically involving flow cytometric enumeration of CD4+FOXP3+…
  • 2021 American Transplant Congress

    Proteomic Analysis of Extracellular Vesicles Derived From a Potent Donor-specific Regulatory T Cell-enriched Population Demonstrates Multiple Markers of Immune Suppression

    B. Schreiber1, S. Tripathi1, M. Blaser2, T. Pham2, S. Kuraoka2, S. A. Singh2, E. Aikawa2, A. Chandraker1

    1Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Boston, MA, 2Center for Interdisciplinary Cardiovascular Sciences, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA

    *Purpose: Extracellular vesicles (EVs) are emerging as vital mediators of intercellular communication and immune regulation. Regulatory T cells (Tregs) play an integral role in immune…
  • 2021 American Transplant Congress

    A Small Molecule Inhibitor of Toll-like Receptor-4 TAK-242 Attenuates IBMIR Against Human Islets

    J. Mattke1, S. Vasu1, K. Kumano1, Y. Liu1, C. M. Darden1, M. C. Lawrence1, R. R. Kane2, B. Naziruddin1

    1Baylor University Medical Ctr, Dallas, TX, 2Baylor University, Waco, TX

    *Purpose: A large portion of grafted islets are lost shortly after infusion due to the instant blood mediated inflammatory reaction (IBMIR). In our previous studies,…
  • 2021 American Transplant Congress

    An Immune-modulatory Strategy to Mitigate Hepatic Ischemia/reperfusion Injury in a Murine Model

    A. Kobayashi, A. Wanchoo, S. Farhadi, J. Simonovich, S. Duarte, V. Boominathan, S. Shrestha, G. Hudalla, B. G. Keselowsky, A. Zarrinpar

    University of Florida, Gainesville, FL

    *Purpose: Hepatic ischemia/reperfusion injury (IRI) is the leading cause of early graft dysfunction and contributes to the shortage of donor liver grafts. However, despite its…
  • 2021 American Transplant Congress

    Myeloid Yap Signaling is Required for Hepatic Cytoprotection in Liver Ischemia-reperfusion Injury

    B. Yang1, Z. Xue1, C. Zhang2, Y. Zhang2, Y. Liu2, J. Kupiec-Weglinski1, H. Ji1

    1Dumont-UCLA Transplant Center, Los Angeles, CA, 2Dept of Surgery, Zhejiang University, Hangzhou, China

    *Purpose: Liver ischemia-reperfusion injury (IRI) is recognized as an innate immunity-driven local inflammation response during hemorrhagic shock, liver resection and transplantation. Yes-associate protein 1 (YAP)…
  • 2021 American Transplant Congress

    Evaluation of Meningococcal Vaccine Response Among Solid Organ Transplant Recipients Receiving Eculizumab

    R. Arora1, C. Kane1, K. Cunningham1, M. Ison2

    1Pharmacy, Northwestern Memorial Hospital, Chicago, IL, 2Divisions of Infectious Diseases and Organ Transplantation, Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Patients receiving eculizumab are at a 1,000-2,000-fold increased risk of invasive meningococcal infections. Therefore, the Advisory Committee for Immunization Practices recommends that these patients…
  • 2021 American Transplant Congress

    Leukopenia in the Renal Transplant Population

    A. Johnson1, G. Karadkhele2, C. Larsen1

    1Emory University, Atlanta, GA, 2Surgery, Emory University, Atlanta, GA

    *Purpose: Leukopenia is a common complication for transplant patients on immunosuppression, but etiologies, timing, and outcomes are only superficially understood.*Methods: All patients undergoing kidney transplant…
  • 2021 American Transplant Congress

    Continuation of Immunosuppression After the First Renal Allograft Failure Impacts Panel Reactive Antibody Status During Subsequent Renal Transplantation

    J. Patel1, S. Ali2, M. L. Sanders3, C. P. Thomas3, D. Axelrod3, M. Bilal4, E. H. Field4, S. Kuppachi3

    1University of Iowa Hospitals & Clinics, Iowa CIty, IA, 2Louis A. Johnson VA Medical Center, Clarksburg, WV, 3University of Iowa Hospitals & Clinics, Iowa City, IA, 4Iowa City VA Health Care System, Iowa City, IA

    *Purpose: The standard of care following renal allograft failure is to discontinue immunosuppression (IS) to limit risks from further IS. We hypothesized that continuation of…
  • 2021 American Transplant Congress

    Is Subclinical Allograft Rejection by 2019 Banff Criteria Associated with Worse Kidney Allograft Outcomes? Comparison Between 2007 and 2019 Banff Criteria

    M. T. Victor1, S. Park2, K. Guo1, L. Zhao1, J. Friedewald3

    1Feinberg School of Medicine, Northwestern University, Chicago, IL, 2Transplant Nephrology, Northwestern Univeristy, Chicago, IL, 3Transplant Nephrology, Northwestern University, Chicago, IL

    *Purpose: We hypothesize that Subclinical Acute Rejection (SubAR) under the new Banff 2019 criteria will be more strongly associated with a 2-year composite endpoint (2Y-CCE)…
  • 2021 American Transplant Congress

    “A New Lease on Life”: Patient Perceptions After Early Liver Transplantation for Alcohol-Related Liver Disease

    R. Greenberg, G. Punchhi, H. Sung, K. Gianaris, M. Krach, K. Herrick-Reynolds, P. Chen, M. Levan, J. Garonzik Wang, A. Cameron

    Johns Hopkins, Baltimore, MD

    *Purpose: At some centers, alcohol-related liver disease (ARLD) patients, who are unlikely to survive six months without a liver transplant (LT), are selected to receive…
  • « Previous Page
  • 1
  • …
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences